Shopping Cart
- Remove All
Your shopping cart is currently empty
STX-0119 is a selective, orally active STAT3 dimerization inhibitor that suppresses STAT3 transcription with an IC50 of 74 μM.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $58 | In Stock | |
| 10 mg | $93 | In Stock | |
| 25 mg | $187 | In Stock | |
| 50 mg | $297 | In Stock | |
| 100 mg | $448 | In Stock | |
| 500 mg | Preferential | In Stock | |
| 1 mL x 10 mM (in DMSO) | $58 | In Stock |
| Description | STX-0119 is a selective, orally active STAT3 dimerization inhibitor that suppresses STAT3 transcription with an IC50 of 74 μM. |
| Targets&IC50 | STAT3:74 μM (STAT3 transcription) |
| In vitro | STX-0119 (10-50 μM; 24 h) inhibits STAT3 dimerization through direct interaction with the STAT3 protein, without affecting upstream regulators like JAK, in HEK293 and MDA-MB-468 cells, and reduces the expression of STAT3 target proteins[1]. |
| In vivo | STX-0119 (160 mg/kg; oral gavage; daily for 4 days) inhibits SCC-3 tumor growth in mice, with plasma concentrations maintained above 100 μg/mL (>260 μM) 8 hours post-administration[1]. |
| Molecular Weight | 382.37 |
| Formula | C22H14N4O3 |
| Cas No. | 851095-32-4 |
| Smiles | C(NC=1OC(=NN1)C2=CC=CO2)(=O)C=3C4=C(N=C(C3)C5=CC=CC=C5)C=CC=C4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 55 mg/mL (143.84 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.